Manufacturing Vaccines for an Emerging Viral Infection–Specific Issues Associated with the Development of a Prototype SARS Vaccine

por Kusters, Inca C., Matthews, James, Saluzzo, Jean François
Publicado en Vaccines for Biodefense and Emerging and Neglected Diseases (2009)

The C-Terminal Region but Not the Arg-X-Pro Repeat of Epstein-Barr Virus Protein EB2 Is Required for Its Effect on RNA Splicing and Transport

por Buisson, Monique, Hans, Fabienne, Kusters, Inca, Duran, Nathalie, Sergeant, Alain
Publicado 1999

Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age

por Vesikari, Timo, Pepin, Stéphanie, Kusters, Inca, Hoffenbach, Agnès, Denis, Martine
Publicado 2012